Literature DB >> 8018333

Characterization of phospholipase A2 from human nasal lavage.

J M Stadel1, K Hoyle, R M Naclerio, A Roshak, F H Chilton.   

Abstract

A secreted form of phospholipase A2 (PLA2) has been implicated in inflammatory disorders such as rheumatoid arthritis and sepsis. To determine if PLA2 may also play a role in allergic rhinitis, we have measured enzymic activity in nasal lavage from allergic subjects. Enhanced activity of PLA2 in the lavage was observed following nasal challenge with antigen or histamine. The PLA2 in the nasal lavage was partially purified by acid extraction, size exclusion chromatography, and ion exchange chromatography. The partially purified enzyme from nasal lavage was subsequently compared to a recombinant form of human PLA2 identified in synovial fluid from arthritic patients. The two enzymes showed similar molecular weights (15 to 16 kD) on SDS-PAGE, and both reacted with a rabbit polyclonal antiserum raised to a galactokinase-PLA2 fusion protein. The enzymatic activities of the two PLA2s were indistinguishable when compared for ionic dependence, substrate selectivity, and sensitivity to inhibitors. These results suggest that the PLA2 induced in nasal lavage in response to challenge by antigen is very similar to the extracellular PLA2 found in synovial fluid from subjects with rheumatoid arthritis and may play a role in the inflammatory processes associated with allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018333     DOI: 10.1165/ajrcmb.11.1.8018333

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  14 in total

1.  Eosinophil cysteinyl leukotriene synthesis mediated by exogenous secreted phospholipase A2 group X.

Authors:  Ying Lai; Rob C Oslund; James G Bollinger; William R Henderson; Luis F Santana; William A Altemeier; Michael H Gelb; Teal S Hallstrand
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

2.  Secreted Phospholipase A2 Group X Acts as an Adjuvant for Type 2 Inflammation, Leading to an Allergen-Specific Immune Response in the Lung.

Authors:  Herbert Luke Ogden; Ying Lai; James D Nolin; Dowon An; Charles W Frevert; Michael H Gelb; William A Altemeier; Teal S Hallstrand
Journal:  J Immunol       Date:  2020-04-27       Impact factor: 5.422

3.  Blockade of human group X secreted phospholipase A2 (GX-sPLA2)-induced airway inflammation and hyperresponsiveness in a mouse asthma model by a selective GX-sPLA2 inhibitor.

Authors:  William R Henderson; Rob C Oslund; James G Bollinger; Xin Ye; Ying-Tzang Tien; Jun Xue; Michael H Gelb
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

Review 4.  Role of cells and mediators in exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; William A Altemeier; Moira L Aitken; William R Henderson
Journal:  Immunol Allergy Clin North Am       Date:  2013-03-29       Impact factor: 3.479

5.  Relationship between levels of secreted phospholipase A₂ groups IIA and X in the airways and asthma severity.

Authors:  T S Hallstrand; Y Lai; Z Ni; R C Oslund; W R Henderson; M H Gelb; S E Wenzel
Journal:  Clin Exp Allergy       Date:  2011-01-24       Impact factor: 5.018

6.  Innate antimicrobial activity of nasal secretions.

Authors:  A M Cole; P Dewan; T Ganz
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

Review 7.  Epithelial regulation of eicosanoid production in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William R Henderson; William A Altemeier; Michael H Gelb
Journal:  Pulm Pharmacol Ther       Date:  2012-12       Impact factor: 3.410

8.  Molecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.

Authors:  Lars Linderoth; Thomas L Andresen; Kent Jørgensen; Robert Madsen; Günther H Peters
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

9.  Regulation and function of epithelial secreted phospholipase A2 group X in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William A Altemeier; Cara L Appel; Brian Johnson; Charles W Frevert; Kelly L Hudkins; James G Bollinger; Prescott G Woodruff; Dallas M Hyde; William R Henderson; Michael H Gelb
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

10.  Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness.

Authors:  Teal S Hallstrand; Emil Y Chi; Alan G Singer; Michael H Gelb; William R Henderson
Journal:  Am J Respir Crit Care Med       Date:  2007-09-27       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.